Monday 16 July 2018

Reuters Health Report: Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic

Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic

Indivior Plc's shares jumped more than 33 percent on Monday after a U.S. court blocked a rival from selling a cheaper copycat of the British drugmaker's bestselling opioid addiction treatment.

Iowa, Illinois investigating infections linked to McDonald's salad

The Iowa and Illinois health departments said on Thursday that they were investigating cyclospora infections linked to salads at McDonald Corp's restaurants.

China pushes for lower cancer drug prices: Xinhua

China's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday.

Indivior wins preliminary injunction against generic rival

A U.S. court has granted Indivior a preliminary injunction blocking India's Dr. Reddy's Laboratories from selling cut-price versions of the British drugmaker's best-selling opioid addiction treatment in the United States, Indivior said on Friday.

J&J vows to overturn $4.7 billion talc verdict but experts see hurdles

Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri.

Within opioid abuse epidemic, infectious disease epidemic emerges

NEW YORK (Reuters Health) - There is a new epidemic of hepatitis C, HIV, and other infections within the opioid abuse epidemic, according to participants in a National Academies of Sciences, Engineering, and Medicine workshop.

Reducing drug possession penalties may have impact on health inequalities

(Reuters Health) - Changing the criminal penalties for drug possession could reduce racial and ethnic disparities in the criminal justice system and indirectly reduce health disparities as well, researchers say.

U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents

A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine.

More women may be experiencing depression during pregnancy

(Reuters Health) - Today's moms-to-be are more likely than women from their mothers' generation to become depressed while pregnant, a study suggests.

Tracking C-section pain patterns may benefit surgical patients

(Reuters Health) - Knowing more about how and when pain starts diminishing after surgery can help doctors and patients understand what's normal and when to expect a full recovery, suggests a small study.

Why Canadian insurers are wary of covering medical marijuana

Sun Life Financial, Canada's No. 2 insurer, recently started covering medical marijuana in its Canadian health insurance plan - more than 17 years after the country first legalized it.

Related Videos

Researchers perfect fingerprint technique to protect pangolins

Scientists hope test-tube embryos can save near-extinct white rhino

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here